A review of sentinel laboratory performance identification and notification of bioterrorism agents

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 10, 2010, Pages 1490-1503

  Wagar, Elizabeth A ^a   Mitchell, Michael J ^b   Carroll, Karen C ^c   Beavis, Kathleen G ^d   Petti, Cathy Anne ^e   Schlaberg, Robert ^f   Yasin, Bushra ^g  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Memorial Health   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d Jr Hospital of Cook County   (United States)

^e Medical and Scientific Affairs Novartis Diagnostics   (United States)

^f UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS ANTHRACIS; BACTERIAL INFECTION; BIOLOGICAL WARFARE; BRUCELLA ABORTUS; CIVIL DEFENSE; CLASSIFICATION; FRANCISELLA TULARENSIS; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; LABORATORY; PATHOLOGY; PUBLIC HEALTH; REVIEW; SENTINEL SURVEILLANCE; STANDARD; UNITED STATES;

BACILLUS ANTHRACIS; BACTERIAL INFECTIONS; BIOTERRORISM; BRUCELLA ABORTUS; CIVIL DEFENSE; DISEASE NOTIFICATION; FRANCISELLA TULARENSIS; HUMANS; LABORATORIES; PATHOLOGY; PUBLIC HEALTH; SENTINEL SURVEILLANCE; UNITED STATES;

EID: 77958603392     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Centers for Disease Control and Prevention. Update: investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep. 2001;50(41):889-893.
2. Centers for Disease Control and Prevention. CDC Laboratory Response Network (LRN): biological terrorism. www.bt.cdc.gov/bioterrorism\responders. asp. Accessed April 29, 2010.
3. Centers for Disease Control and Prevention. The Laboratory Response Network: partners in preparedness.http://www.bt.cdc.gov/lrn/. Accessed March 16, 2010.
4. American Society for Microbiology. Sentinel laboratory guidelines for suspected agents of bioterrorism: clinical laboratory bioterrorism readiness plan. Coordinating ed, JamesW. Snyder. http://www.asm.org/?option5com- content&view5article&id56342&Itemid5639. Revised August 10, 2006. Accessed April 7, 2010.
5. Association of Public Health Laboratories. LRN Sentinel Laboratories: Clinical. http://www.aphl.org/aphlprograms/ep/Documents/LRN-Sentinel-Clinical. pdf. Disseminated April 2006. Accessed March 16, 2010.
6. Sewell DL. Laboratory safety practices associated with potential agents of biocrime or bioterrorism. J Clin Microbiol. 2003;41(7):2801-2809.
7. Kyriacou D, Adamski A, Khardori N. Anthrax: from antiquity and obscurity to a front-runner in bioterrorism. Infect Dis Clin N Amer. 2006;20(2):227-251.
8. Cheng A, Currie B. Melioidosis; epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005;18(2):383-416.
9. Inglis T, Merritt A, Chidlow G, Aravena-Roman M, Harnett G. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J Clin Microbiol. 2005;43(5):2201-2206.
10. Centers for Disease Control and Prevention/National Institutes of Health. Agent summary statements: agent Burkholderia pseudomallei. In: Chosewood L, Wilson D, eds. Biosafety in Microbiology and Biomedical Laboratories. 5th ed. Washington, DC: US Government Printing Office; 2007:141-142.
11. Bockemuhl J, Wong J. Yersinia. In: Murray P, Baron E, Jorgensen J, et al, eds. Manual of Clinical Microbiology. Vol 1. 8th ed. Washington, DC: ASM Press; 2005:672-683.
12. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. JAMA. 2000;283(17):2281-2290.
13. Lindquist D, Chu M, Probert W. Francisella and Brucella. In: Murray P, Baron E, Jorgensen J, et al, eds. Manual of Clinical Microbiology. 9th ed. Washington, DC: ASM Press; 2007:815-834.
14. Penn R. Francisella tularensis (tularemia). In: Mandell G, Bennett J, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadephia, PA: Elsevier Churchill Livingstone; 2005:2674-2685.
15. Centers for Disease Control and Prevention. Update: potential exposures to attenuated vaccine strain Brucella abortus RB51 during a laboratory proficiency test-United States and Canada, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(2):36-39.
16. Peterson LR, Hamilton JD, Baron EJ, et al. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis. 2001;32(4):605-611.
17. Schurig G, Roop RM II, Bagchi T, Boyle S, Buhrman D, Sriranganathan N. Biological properties of RB-51: a stable rough strain of Brucella abortus. Vet Microbiol. 1991;28(2):171-188.
18. Centers for Disease Control and Prevention. Human exposure to Brucella abortus RB-51-Kansas, 1997. MMWR Morb Mortal Wkly Rep. 47(9):172-175.
19. Efstratiou A, Engler K, Mazurova I, Glushkevich T, Vuopio-Varkila J, Popovic T. Current approaches to the laboratory diagnosis of diphtheria. J Infect Dis. 2000;181(suppl 1):S138-S145.
20. Golaz A, Hardy I, Strebel P, et al. Epidemic diphtheria in the newly independent states of the former Soviet Union: implications for diphtheria control in the United States. J Infect Dis. 2000;181(suppl 1):S237-S243.
21. Funke G, Benard K. Coryneform gram-positive rods. In: Murray P, Baron E, Jorgensen J, et al, eds. Manual of Clinical Microbiology. 9th ed. Washington DC: ASM Press; 2007:485-514.
22. Larone D. Coccidioidmycosis. In: Larone D, ed. Medically Important Fungi: A Guide to Identification. 4th ed. Washington, DC: ASM Press; 2002:58.
23. Sutton D, Fothergill A, Rinald M. Guide to Clinically Significant Fungi. 1st ed. Baltimore, MD: Williams & Wilkins; 1998.
24. Centers for Disease Control and Prevention. Emergency preparedness and response. http://emergency.cdc.gov/agent/agentlist.asp. AccessedMarch 16, 2010.
25. Wagar EA, Stankovic AK, Raab S, Nakhleh RE, Walsh MK. Specimen labeling errors: a Q-Probes analysis of 147 clinical laboratories. Arch Pathol Lab Med. 2008:132(10):1617-1622.
26. Margolis DA, Burns J, Reed SL, Ginsberg MM, O'Grady TC, Vinetz JM. Case report: septicemic plague in a community hospital in California. Am J Trop Med Hyg. 2008;78(6):868-871.
27. Bergier EM, Barrett NL, Mshar PA, Johnson DG, Hadler JL; Connecticut Bioterrorism Field Epidemiology Response Team. Gram-positive rod surveillance for early anthrax detection. Emerg Infect Dis. 2005;11(9):1483-1486.
28. Snyder JW. Role of the hospital-based microbiology laboratory in preparation for and response to a bioterrorism event. J Clin Microbiol. 2003; 41(1):1-4.
29. Kalish BT, Gaydos CA, Hsieh Y-H, et al. National survey of Laboratory Response Network sentinel laboratory preparedness. Disaster Med Public Health Prep. 2009;3(suppl 2):S17-S23.